Literature DB >> 28830221

PI-RADS version 2: evaluation of diffusion-weighted imaging interpretation between b = 1000 and b = 1500 s mm-2.

Mi-Ri Kwon1, Chan Kyo Kim1,2, Jae-Hun Kim1.   

Abstract

OBJECTIVE: To investigate the variability of diffusion-weighted imaging (DWI) interpretation of Prostate Imaging Reporting and Data System (PI-RADS) version 2 (v2) in evaluating prostate cancer (PCa).
METHODS: 154 patients with PCa underwent multiparametric 3T MRI, followed by radical prostatectomy. DWI with different b values (b = 0, 100, 1000 and 1500 s mm-2) was obtained. Using the PI-RADS v2, two radiologists independently scored suspicious lesions in each patient and compared DWI of b = 1000 (DWI1000) with 1500 (DWI1500) s mm-2.
RESULTS: On DWI1000 and DWI1500, the intermethod and interobserver agreements of DWI scores were excellent in all patients (κ ≥ 0.873). In each peripheral zone and transition zone DWI scores, both observers showed excellent intermethod agreement between DWI1000 and DWI1500 (κ ≥ 0.897), and interobserver agreement for DWI1000 and DWI1500 was good to excellent (κ ≥ 0.796). For estimating clinically significant cancer, the area under receiver operating characteristics curves of DWI1000 and DWI1500 were 0.710 and 0.724 for observer 1 (p = 0.11), and 0.649 and 0.656 for observer 2 (p = 0.12), respectively.
CONCLUSION: The PI-RADS v2 scoring at 3T shows excellent agreement between DWI1000 and DWI1500 in evaluating PCa, with excellent inter-observer agreement. Advance in knowledge: DWI using b = 1000 s mm-2 instead of b = 1500 s mm-2 reduces examination time or image distortion, with improved the signal-to-noise ratio.

Entities:  

Mesh:

Year:  2017        PMID: 28830221      PMCID: PMC5963389          DOI: 10.1259/bjr.20170438

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  20 in total

1.  Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed?

Authors:  Thomas de Perrot; Max Scheffler; José Boto; Bénédicte M A Delattre; Christophe Combescure; Marc Pusztaszeri; Jean-Christophe Tille; Christophe Iselin; Jean-Paul Vallée
Journal:  J Magn Reson Imaging       Date:  2016-02-23       Impact factor: 4.813

2.  Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer.

Authors:  Yoshimitsu Ohgiya; Jumpei Suyama; Noritaka Seino; Takashi Hashizume; Masaaki Kawahara; Syouei Sai; Makoto Saiki; Jiro Munechika; Masanori Hirose; Takehiko Gokan
Journal:  Clin Imaging       Date:  2012-06-08       Impact factor: 1.605

3.  Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.

Authors:  Andrew B Rosenkrantz; Nicole Hindman; Ruth P Lim; Kasturi Das; James S Babb; Thais C Mussi; Samir S Taneja
Journal:  J Magn Reson Imaging       Date:  2013-01-31       Impact factor: 4.813

4.  Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.

Authors:  Andrew B Rosenkrantz; Luke A Ginocchio; Daniel Cornfeld; Adam T Froemming; Rajan T Gupta; Baris Turkbey; Antonio C Westphalen; James S Babb; Daniel J Margolis
Journal:  Radiology       Date:  2016-04-01       Impact factor: 11.105

5.  High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T.

Authors:  X Wang; Y Qian; B Liu; L Cao; Y Fan; J J Zhang; Y Yu
Journal:  Clin Radiol       Date:  2014-08-30       Impact factor: 2.350

6.  Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging.

Authors:  Berrend G Muller; Joanna H Shih; Sandeep Sankineni; Jamie Marko; Soroush Rais-Bahrami; Arvin Koruthu George; Jean J M C H de la Rosette; Maria J Merino; Bradford J Wood; Peter Pinto; Peter L Choyke; Baris Turkbey
Journal:  Radiology       Date:  2015-06-18       Impact factor: 11.105

7.  What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?

Authors:  T Metens; D Miranda; J Absil; C Matos
Journal:  Eur Radiol       Date:  2011-10-05       Impact factor: 5.315

8.  Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.

Authors:  Harsh K Agarwal; Francesca V Mertan; Sandeep Sankineni; Marcelino Bernardo; Julien Senegas; Jochen Keupp; Dagane Daar; Maria Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  J Magn Reson Imaging       Date:  2016-07-07       Impact factor: 4.813

9.  PI-RADS version 2: quantitative analysis aids reliable interpretation of diffusion-weighted imaging for prostate cancer.

Authors:  Sung Yoon Park; Su-Jin Shin; Dae Chul Jung; Nam Hoon Cho; Young Deuk Choi; Koon Ho Rha; Sung Joon Hong; Young Taik Oh
Journal:  Eur Radiol       Date:  2016-12-12       Impact factor: 5.315

10.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

View more
  4 in total

Review 1.  Computed Diffusion-Weighted Imaging in Prostate Cancer: Basics, Advantages, Cautions, and Future Prospects.

Authors:  Yoshiko R Ueno; Tsutomu Tamada; Satoru Takahashi; Utaru Tanaka; Keitaro Sofue; Tomonori Kanda; Munenobu Nogami; Yoshiharu Ohno; Nobuyuki Hinata; Masato Fujisawa; Takamichi Murakami
Journal:  Korean J Radiol       Date:  2018-08-06       Impact factor: 3.500

2.  Prognostic Significance for Long-Term Outcomes Following Radical Prostatectomy in Men with Prostate Cancer: Evaluation with Prostate Imaging Reporting and Data System Version 2.

Authors:  Ran Kim; Chan Kyo Kim; Jung Jae Park; Jae Hun Kim; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee
Journal:  Korean J Radiol       Date:  2019-02       Impact factor: 3.500

Review 3.  Diffusion-Weighted MRI in the Genitourinary System.

Authors:  Thomas De Perrot; Christine Sadjo Zoua; Carl G Glessgen; Diomidis Botsikas; Lena Berchtold; Rares Salomir; Sophie De Seigneux; Harriet C Thoeny; Jean-Paul Vallée
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

4.  Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.

Authors:  Francesco Giganti; Eoin Dinneen; Veeru Kasivisvanathan; Aiman Haider; Alex Freeman; Alex Kirkham; Shonit Punwani; Mark Emberton; Greg Shaw; Caroline M Moore; Clare Allen
Journal:  Eur Radiol       Date:  2021-07-29       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.